Key Market Indicator:
Ad-hoc news is mandatory information from listed companies that must be made available to investors. Depending on the occasion and content of the news, it can have an impact on the share price. The newsfeed covers a wide range of topics relevant to investor relations and is recommended as an important source of information before making an investment decision.
Thu, 23.10.2025
KION GROUP AG
Disclosure of Inside Information pursuant to Article 17 of Regulation (EU) No. 596/2014
Keywords: Forecast
KION GROUP AG
Thea-Rasche-Straße 8
60549 Frankfurt am Main
ISIN DE000KGX8881KION GROUP AG: KION Group adjusts free cash flow outlook for 2025 due to lower one-time expenses for efficiency program; cost savings expected to remain nearly unchang [ … ]
Thu, 23.10.2025
hGears AG
hGears AG increases its forecast for adjusted EBITDA and free cash flow for the full year 2025
Publication of inside information pursuant to Article 17 of Regulation (EU) No. 596/2014
Schramberg 23 October 2025 – Based on the latest order indicators and expectations regarding business development, the Management Board of hGears AG has raised its [ … ]
Thu, 23.10.2025
WashTec AG
The Management Board of WashTec AG (the "Company") today resolved, with the approval of the Supervisory Board, to exercise the authorization granted by the Annual General Meeting on May 13, 2025, to implement a program to repurchase the Company's own shares with a total volume of up to €5.0m euros (total purchase price excluding incidental acquisit [ … ]
Thu, 23.10.2025
INFICON Holding AG
Corporate ContactMatthias TröndleChief Financial Officer+423 388 3510 matthias.troendle@inficon.com'Ad hoc announcement pursuant to Art. 53 LR'
Announcement of INFICON Holding AG
Bad Ragaz/Switzerland, October 23, 2025
Book-to-bill ratio above 1 for the third consecutive quarter. Orders increase substantially year-on-year in all end markets and m [ … ]
Thu, 23.10.2025
Gurit Holding AG
Zurich, October 23, 2025 – Ad hoc announcement pursuant to Art. 53 LR
Gurit (SIX Swiss Exchange: GURN) today reports unaudited net sales for the first nine months of 2025 at CHF 239.9 million, marking a decrease of -20.3% at constant exchange rates or -23.9% in reported CHF compared to the same period in 2024. Third-quarter sales were affected by p [ … ]
Thu, 23.10.2025
Galenica AG
Press releaseAd hoc announcement pursuant to Art. 53 LR
Galenica Group sales grew 4.7% to CHF 2,999.7 million in the third quarter of 2025.
Sales growth is driven by prescription drugs and dietary supplements.
Thanks to the acquisition of Labor Team, Galenica now expects sales growth of between 4% and 6% and an increase in EBIT1 of between 10% an [ … ]
Thu, 23.10.2025
Lonza Group AG
Ad hoc announcement pursuant to Art. 53 LR
Strong CDMO1 performance in Q3 2025 in Integrated Biologics and Advanced Synthesis, while Specialized Modalities improved versus a soft H1
Large contract signings in Q3, including another significant commercial contract for Vacaville
Capsules & Health Ingredients (CHI) returned to growth as expected [ … ]
Wed, 22.10.2025
YOC AG
Publication of inside information in accordance with Article 17 of Regulation (EU) No. 596/2014
YOC AG: Preliminary figures for Q3/2025 – Adjustment of the full-year guidance
Berlin, October 22, 2025 – Based on preliminary figures for the third quarter of 2025, YOC AG (ISIN DE0005932735) generated earnings before interest, taxes, depreciation, a [ … ]
Wed, 22.10.2025
H&R GmbH & Co. KGaA
Insider information pursuant to Article 17
of the Market Abuse Regulation [MAR]
H&R GmbH & Co. KGaA: Preliminary Figures for nine month period of 2025
Business slows down in terms of sales revenue and earnings
EBITDA at EUR 60.5 million, around 8 percent below the previous year's level (nine months of 2024: EUR 65.9 million)
Salzberg [ … ]
Wed, 22.10.2025
DocMorris AG
Frauenfeld, 22 October 2025
Press release
Ad hoc announcement pursuant to Art. 53 LR
DocMorris successfully completes the placement of CHF 49.6 million Convertible Bonds due 2028
DocMorris Finance B.V. (the “Issuer”), a directly wholly-owned subsidiary of DocMorris AG (the “Company” or “DocMorris”), successfully completed the offering (the “New [ … ]
